id int64 | platform_type string | seller_id string | platform_name string | product_name string | product_category string | prescription_required_legally int64 | prescription_verified int64 | product_registered int64 | seller_licensed int64 | pharmacist_consultation int64 | verified_supply_chain int64 | cold_chain_maintained int64 | manufacturer_origin string | quality_test_result string | sf_classification string | API_content_adequate int64 | price_vs_reference float64 | payment_method string | consumer_age_group string | consumer_education string | consumer_complaint_filed int64 | adverse_event_reported int64 | website_takedown int64 | year int64 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
501 | social_media | EPHARM_00340 | Instagram | antimalarial | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | China | fail | falsified | 0 | 0.81 | cash_on_delivery | 25_34 | secondary | 0 | 0 | 0 | 2,024 |
502 | social_media | EPHARM_00854 | dedicated_website | antimalarial | essential | 1 | 1 | 0 | 0 | 0 | 0 | 0 | India | fail | falsified | 0 | 0.53 | cash_on_delivery | 18_24 | tertiary | 0 | 0 | 0 | 2,024 |
503 | social_media | EPHARM_00939 | Telegram | supplement_vitamin | OTC | 0 | 0 | 1 | 0 | 0 | 0 | 0 | local_SSA | fail | substandard | 1 | 0.84 | mobile_money | 35_49 | primary | 0 | 0 | 0 | 2,023 |
504 | social_media | EPHARM_00225 | Telegram | antimalarial | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 0 | 0.52 | bank_transfer | 25_34 | tertiary | 0 | 0 | 0 | 2,024 |
505 | social_media | EPHARM_00267 | darknet_market | supplement_vitamin | OTC | 0 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | substandard | 1 | 0.83 | bank_transfer | 25_34 | primary | 0 | 0 | 0 | 2,020 |
506 | social_media | EPHARM_00965 | marketplace_app | traditional_herbal | unregulated | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | falsified | 0 | 0.57 | mobile_money | 18_24 | primary | 1 | 0 | 0 | 2,022 |
507 | social_media | EPHARM_00321 | marketplace_app | supplement_vitamin | OTC | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.36 | cryptocurrency | 18_24 | tertiary | 0 | 0 | 0 | 2,023 |
508 | social_media | EPHARM_00127 | marketplace_app | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | USA | fail | falsified | 0 | 0.64 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,023 |
509 | social_media | EPHARM_00746 | marketplace_app | antihypertensive | NCD | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.49 | cash_on_delivery | 25_34 | primary | 0 | 0 | 0 | 2,020 |
510 | social_media | EPHARM_00803 | marketplace_app | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.54 | cash_on_delivery | 35_49 | primary | 1 | 0 | 0 | 2,024 |
511 | social_media | EPHARM_00318 | Facebook | antimalarial | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.28 | mobile_money | 18_24 | primary | 1 | 0 | 0 | 2,020 |
512 | social_media | EPHARM_00814 | Instagram | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.85 | mobile_money | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
513 | social_media | EPHARM_00651 | darknet_market | weight_loss | lifestyle | 0 | 0 | 0 | 1 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.83 | credit_card | 25_34 | secondary | 0 | 0 | 0 | 2,024 |
514 | social_media | EPHARM_00056 | dedicated_website | COVID_treatment | pandemic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | local_SSA | fail | falsified | 0 | 0.42 | cash_on_delivery | 35_49 | secondary | 0 | 1 | 0 | 2,024 |
515 | social_media | EPHARM_00607 | Facebook | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | falsified | 1 | 0.48 | bank_transfer | 18_24 | tertiary | 1 | 0 | 0 | 2,024 |
516 | social_media | EPHARM_00361 | dedicated_website | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | fail | falsified | 0 | 0.85 | mobile_money | 50_plus | tertiary | 0 | 1 | 0 | 2,023 |
517 | social_media | EPHARM_00753 | WhatsApp | traditional_herbal | unregulated | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 1 | 0.7 | cash_on_delivery | 35_49 | secondary | 0 | 0 | 0 | 2,021 |
518 | social_media | EPHARM_00504 | dedicated_website | traditional_herbal | unregulated | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.94 | cash_on_delivery | 25_34 | primary | 1 | 0 | 0 | 2,024 |
519 | social_media | EPHARM_00699 | marketplace_app | antimalarial | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 1 | 0.63 | mobile_money | 35_49 | tertiary | 0 | 1 | 0 | 2,022 |
520 | social_media | EPHARM_00034 | dedicated_website | antimalarial | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 1.17 | bank_transfer | 18_24 | tertiary | 1 | 1 | 0 | 2,023 |
521 | social_media | EPHARM_00791 | dedicated_website | antidiabetic | NCD | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 0 | 0.65 | credit_card | 25_34 | tertiary | 0 | 0 | 0 | 2,022 |
522 | social_media | EPHARM_00180 | Instagram | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 1 | 0.93 | mobile_money | 18_24 | secondary | 1 | 0 | 0 | 2,021 |
523 | social_media | EPHARM_00548 | dedicated_website | antimalarial | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.82 | mobile_money | 25_34 | tertiary | 0 | 0 | 0 | 2,024 |
524 | social_media | EPHARM_00319 | Facebook | traditional_herbal | unregulated | 0 | 0 | 1 | 0 | 0 | 0 | 0 | USA | pass | compliant | 1 | 0.77 | cash_on_delivery | 25_34 | secondary | 1 | 0 | 0 | 2,023 |
525 | social_media | EPHARM_00361 | Instagram | benzodiazepine | controlled | 1 | 0 | 0 | 0 | 0 | 1 | 1 | unknown | fail | substandard | 0 | 0.72 | bank_transfer | 35_49 | tertiary | 0 | 0 | 0 | 2,020 |
526 | social_media | EPHARM_00659 | dedicated_website | supplement_vitamin | OTC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.36 | cash_on_delivery | 18_24 | tertiary | 0 | 0 | 0 | 2,021 |
527 | social_media | EPHARM_00066 | dedicated_website | skin_lightening | cosmetic | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 1 | 0.72 | mobile_money | 50_plus | primary | 0 | 0 | 0 | 2,024 |
528 | social_media | EPHARM_00957 | marketplace_app | antihypertensive | NCD | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.57 | credit_card | 25_34 | secondary | 0 | 0 | 0 | 2,021 |
529 | social_media | EPHARM_00050 | Facebook | antibiotic | prescription | 1 | 0 | 1 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.75 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,020 |
530 | social_media | EPHARM_00127 | marketplace_app | antibiotic | prescription | 1 | 0 | 0 | 0 | 1 | 1 | 0 | unknown | fail | substandard | 0 | 1.07 | bank_transfer | 25_34 | secondary | 0 | 0 | 0 | 2,021 |
531 | social_media | EPHARM_00003 | Telegram | antimalarial | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | Europe | fail | substandard | 0 | 0.81 | cash_on_delivery | 18_24 | tertiary | 0 | 0 | 0 | 2,023 |
532 | social_media | EPHARM_00561 | Facebook | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 1.19 | mobile_money | 25_34 | primary | 0 | 0 | 0 | 2,024 |
533 | social_media | EPHARM_00996 | marketplace_app | antihypertensive | NCD | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | falsified | 0 | 0.57 | mobile_money | 25_34 | tertiary | 0 | 0 | 1 | 2,020 |
534 | social_media | EPHARM_00629 | dedicated_website | skin_lightening | cosmetic | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 0 | 0.69 | cash_on_delivery | 25_34 | secondary | 0 | 0 | 0 | 2,021 |
535 | social_media | EPHARM_00515 | Telegram | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 1 | China | fail | substandard | 1 | 0.56 | credit_card | 25_34 | tertiary | 0 | 0 | 0 | 2,022 |
536 | social_media | EPHARM_00360 | darknet_market | COVID_treatment | pandemic | 0 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | substandard | 0 | 0.55 | credit_card | 35_49 | secondary | 1 | 0 | 0 | 2,023 |
537 | social_media | EPHARM_00429 | darknet_market | antihypertensive | NCD | 1 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 0 | 0.7 | cryptocurrency | 25_34 | primary | 0 | 0 | 0 | 2,023 |
538 | social_media | EPHARM_00047 | darknet_market | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Europe | fail | substandard | 0 | 0.77 | bank_transfer | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
539 | social_media | EPHARM_00400 | Telegram | skin_lightening | cosmetic | 0 | 0 | 0 | 0 | 0 | 0 | 1 | India | fail | falsified | 1 | 0.74 | cryptocurrency | 25_34 | primary | 1 | 0 | 0 | 2,024 |
540 | social_media | EPHARM_00974 | Instagram | antidiabetic | NCD | 1 | 0 | 1 | 1 | 0 | 0 | 0 | Europe | pass | compliant | 1 | 1.16 | cryptocurrency | 25_34 | secondary | 0 | 0 | 0 | 2,023 |
541 | social_media | EPHARM_00544 | dedicated_website | antihypertensive | NCD | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.95 | credit_card | 18_24 | primary | 1 | 0 | 0 | 2,024 |
542 | social_media | EPHARM_00680 | dedicated_website | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 1 | 0 | unknown | fail | substandard | 0 | 0.74 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,023 |
543 | social_media | EPHARM_00196 | Telegram | traditional_herbal | unregulated | 0 | 0 | 1 | 0 | 0 | 0 | 0 | India | fail | substandard | 1 | 0.61 | mobile_money | 25_34 | primary | 1 | 0 | 0 | 2,024 |
544 | social_media | EPHARM_00055 | TikTok | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.6 | bank_transfer | 35_49 | primary | 0 | 0 | 0 | 2,022 |
545 | social_media | EPHARM_00527 | Facebook | supplement_vitamin | OTC | 0 | 0 | 1 | 0 | 0 | 0 | 0 | local_SSA | pass | compliant | 1 | 0.59 | cryptocurrency | 18_24 | primary | 0 | 0 | 0 | 2,024 |
546 | social_media | EPHARM_00996 | marketplace_app | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | local_SSA | pass | compliant | 1 | 0.79 | mobile_money | 35_49 | secondary | 0 | 0 | 0 | 2,021 |
547 | social_media | EPHARM_00317 | Instagram | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | falsified | 1 | 0.94 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,020 |
548 | social_media | EPHARM_00468 | darknet_market | antihypertensive | NCD | 1 | 0 | 0 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.78 | cash_on_delivery | 25_34 | primary | 1 | 0 | 0 | 2,024 |
549 | social_media | EPHARM_00516 | dedicated_website | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.59 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
550 | social_media | EPHARM_00756 | WhatsApp | benzodiazepine | controlled | 1 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 1 | 0.81 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,023 |
551 | social_media | EPHARM_00814 | marketplace_app | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.67 | credit_card | 25_34 | primary | 0 | 0 | 0 | 2,023 |
552 | social_media | EPHARM_00161 | marketplace_app | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.67 | cryptocurrency | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
553 | social_media | EPHARM_00873 | dedicated_website | benzodiazepine | controlled | 1 | 0 | 1 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 1.05 | bank_transfer | 35_49 | secondary | 0 | 0 | 0 | 2,020 |
554 | social_media | EPHARM_00415 | darknet_market | contraceptive | reproductive | 0 | 0 | 1 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.53 | cash_on_delivery | 18_24 | secondary | 0 | 0 | 0 | 2,023 |
555 | social_media | EPHARM_00046 | Instagram | antihypertensive | NCD | 1 | 1 | 1 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.39 | mobile_money | 50_plus | tertiary | 1 | 0 | 0 | 2,024 |
556 | social_media | EPHARM_00378 | dedicated_website | antihypertensive | NCD | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.78 | cash_on_delivery | 25_34 | secondary | 0 | 0 | 0 | 2,022 |
557 | social_media | EPHARM_00512 | TikTok | skin_lightening | cosmetic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | fail | falsified | 1 | 0.36 | cash_on_delivery | 18_24 | tertiary | 0 | 1 | 0 | 2,021 |
558 | social_media | EPHARM_00725 | Facebook | skin_lightening | cosmetic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 0 | 0.57 | cryptocurrency | 35_49 | tertiary | 0 | 0 | 0 | 2,023 |
559 | social_media | EPHARM_00295 | marketplace_app | antimalarial | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.65 | cash_on_delivery | 18_24 | tertiary | 0 | 0 | 0 | 2,024 |
560 | social_media | EPHARM_00985 | marketplace_app | opioid_analgesic | controlled | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | falsified | 0 | 0.61 | mobile_money | 50_plus | tertiary | 0 | 0 | 0 | 2,024 |
561 | social_media | EPHARM_00481 | WhatsApp | antidiabetic | NCD | 1 | 1 | 0 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.66 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
562 | social_media | EPHARM_00519 | Telegram | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.86 | credit_card | 50_plus | secondary | 0 | 0 | 0 | 2,024 |
563 | social_media | EPHARM_00045 | Instagram | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 1 | 0 | China | fail | falsified | 0 | 0.72 | bank_transfer | 35_49 | secondary | 0 | 0 | 0 | 2,022 |
564 | social_media | EPHARM_00636 | darknet_market | traditional_herbal | unregulated | 0 | 0 | 1 | 0 | 1 | 0 | 0 | unknown | fail | substandard | 0 | 0.5 | mobile_money | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
565 | social_media | EPHARM_00148 | dedicated_website | ARV_HIV | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.56 | mobile_money | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
566 | social_media | EPHARM_00062 | Facebook | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | local_SSA | fail | substandard | 0 | 0.82 | cash_on_delivery | 25_34 | primary | 0 | 0 | 0 | 2,024 |
567 | social_media | EPHARM_00252 | dedicated_website | weight_loss | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.92 | cash_on_delivery | 50_plus | secondary | 0 | 0 | 0 | 2,023 |
568 | social_media | EPHARM_00775 | Telegram | contraceptive | reproductive | 0 | 0 | 0 | 0 | 0 | 0 | 1 | India | pass | compliant | 1 | 0.52 | bank_transfer | 18_24 | tertiary | 0 | 0 | 0 | 2,023 |
569 | social_media | EPHARM_00051 | dedicated_website | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.55 | mobile_money | 18_24 | tertiary | 0 | 0 | 0 | 2,022 |
570 | social_media | EPHARM_00233 | marketplace_app | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.87 | credit_card | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
571 | social_media | EPHARM_00818 | dedicated_website | skin_lightening | cosmetic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 1 | 0.65 | bank_transfer | 25_34 | tertiary | 0 | 0 | 0 | 2,021 |
572 | social_media | EPHARM_00427 | marketplace_app | ARV_HIV | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.95 | cryptocurrency | 25_34 | secondary | 0 | 0 | 0 | 2,022 |
573 | social_media | EPHARM_00520 | darknet_market | cancer_medicine | specialty | 1 | 1 | 1 | 0 | 0 | 0 | 0 | USA | pass | compliant | 1 | 0.81 | mobile_money | 25_34 | tertiary | 0 | 0 | 0 | 2,023 |
574 | social_media | EPHARM_00756 | darknet_market | supplement_vitamin | OTC | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Europe | fail | falsified | 0 | 0.74 | mobile_money | 35_49 | secondary | 1 | 0 | 0 | 2,024 |
575 | social_media | EPHARM_00547 | dedicated_website | antimalarial | essential | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.63 | credit_card | 50_plus | tertiary | 1 | 0 | 0 | 2,023 |
576 | social_media | EPHARM_00609 | Instagram | traditional_herbal | unregulated | 0 | 0 | 1 | 0 | 0 | 0 | 0 | Europe | pass | compliant | 1 | 0.81 | mobile_money | 35_49 | secondary | 0 | 0 | 0 | 2,024 |
577 | social_media | EPHARM_00554 | dedicated_website | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | USA | fail | substandard | 1 | 0.66 | bank_transfer | 25_34 | tertiary | 0 | 0 | 0 | 2,022 |
578 | social_media | EPHARM_00243 | dedicated_website | skin_lightening | cosmetic | 0 | 0 | 1 | 0 | 0 | 0 | 0 | China | pass | compliant | 1 | 0.62 | mobile_money | 35_49 | secondary | 0 | 0 | 0 | 2,021 |
579 | social_media | EPHARM_00048 | dedicated_website | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | fail | substandard | 0 | 0.49 | mobile_money | 50_plus | secondary | 1 | 0 | 0 | 2,024 |
580 | social_media | EPHARM_00415 | dedicated_website | antidiabetic | NCD | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 0 | 0.65 | bank_transfer | 18_24 | tertiary | 1 | 0 | 0 | 2,023 |
581 | social_media | EPHARM_00724 | WhatsApp | antihypertensive | NCD | 1 | 0 | 1 | 0 | 0 | 0 | 0 | China | fail | substandard | 0 | 0.84 | cash_on_delivery | 25_34 | secondary | 0 | 0 | 0 | 2,024 |
582 | social_media | EPHARM_00859 | dedicated_website | antihypertensive | NCD | 1 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 0 | 0.33 | cash_on_delivery | 50_plus | tertiary | 0 | 0 | 0 | 2,022 |
583 | social_media | EPHARM_00102 | dedicated_website | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 1 | 0 | unknown | fail | falsified | 0 | 0.7 | mobile_money | 18_24 | tertiary | 0 | 0 | 0 | 2,021 |
584 | social_media | EPHARM_00293 | dedicated_website | antibiotic | prescription | 1 | 1 | 1 | 0 | 1 | 0 | 0 | unknown | fail | substandard | 1 | 0.93 | cash_on_delivery | 25_34 | secondary | 0 | 0 | 0 | 2,022 |
585 | social_media | EPHARM_00839 | dedicated_website | traditional_herbal | unregulated | 0 | 0 | 0 | 0 | 0 | 0 | 0 | China | fail | falsified | 1 | 0.41 | cash_on_delivery | 35_49 | primary | 1 | 0 | 0 | 2,024 |
586 | social_media | EPHARM_00018 | Facebook | antihypertensive | NCD | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | substandard | 0 | 0.93 | mobile_money | 18_24 | tertiary | 0 | 0 | 0 | 2,022 |
587 | social_media | EPHARM_00373 | WhatsApp | benzodiazepine | controlled | 1 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.91 | cryptocurrency | 35_49 | tertiary | 0 | 0 | 0 | 2,024 |
588 | social_media | EPHARM_00649 | Facebook | skin_lightening | cosmetic | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | fail | falsified | 0 | 0.5 | cash_on_delivery | 18_24 | secondary | 0 | 0 | 0 | 2,022 |
589 | social_media | EPHARM_00007 | Instagram | antimalarial | essential | 1 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 0 | 0.78 | credit_card | 18_24 | primary | 0 | 0 | 0 | 2,023 |
590 | social_media | EPHARM_00488 | Instagram | erectile_dysfunction | lifestyle | 0 | 0 | 1 | 0 | 0 | 0 | 0 | USA | pass | compliant | 1 | 0.59 | mobile_money | 35_49 | secondary | 1 | 0 | 0 | 2,023 |
591 | social_media | EPHARM_00521 | dedicated_website | traditional_herbal | unregulated | 0 | 0 | 1 | 0 | 0 | 0 | 0 | unknown | pass | compliant | 1 | 0.59 | mobile_money | 50_plus | primary | 0 | 0 | 0 | 2,023 |
592 | social_media | EPHARM_00850 | dedicated_website | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 1 | 0 | India | fail | falsified | 0 | 1.31 | mobile_money | 25_34 | tertiary | 1 | 0 | 0 | 2,023 |
593 | social_media | EPHARM_00927 | Telegram | opioid_analgesic | controlled | 1 | 0 | 0 | 0 | 0 | 0 | 0 | local_SSA | fail | falsified | 0 | 0.45 | cash_on_delivery | 35_49 | primary | 0 | 0 | 0 | 2,023 |
594 | social_media | EPHARM_00956 | WhatsApp | erectile_dysfunction | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | India | pass | compliant | 1 | 0.88 | credit_card | 25_34 | tertiary | 0 | 0 | 0 | 2,024 |
595 | social_media | EPHARM_00461 | marketplace_app | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 1 | 0 | unknown | fail | substandard | 0 | 0.75 | mobile_money | 25_34 | secondary | 0 | 0 | 0 | 2,024 |
596 | social_media | EPHARM_00631 | Facebook | antibiotic | prescription | 1 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | falsified | 1 | 0.78 | cash_on_delivery | 18_24 | secondary | 0 | 0 | 0 | 2,022 |
597 | social_media | EPHARM_00318 | Facebook | weight_loss | lifestyle | 0 | 0 | 0 | 0 | 0 | 0 | 0 | unknown | fail | substandard | 1 | 1.14 | mobile_money | 35_49 | primary | 1 | 0 | 0 | 2,021 |
598 | social_media | EPHARM_00513 | WhatsApp | traditional_herbal | unregulated | 0 | 0 | 0 | 0 | 0 | 0 | 0 | Europe | fail | falsified | 1 | 0.83 | mobile_money | 25_34 | secondary | 1 | 0 | 0 | 2,024 |
599 | social_media | EPHARM_00857 | dedicated_website | antimalarial | essential | 1 | 0 | 1 | 0 | 0 | 0 | 1 | India | fail | substandard | 0 | 0.58 | bank_transfer | 35_49 | secondary | 0 | 0 | 0 | 2,022 |
600 | social_media | EPHARM_00256 | marketplace_app | contraceptive | reproductive | 0 | 0 | 0 | 0 | 1 | 0 | 0 | India | fail | substandard | 1 | 0.49 | cash_on_delivery | 35_49 | primary | 0 | 0 | 0 | 2,024 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.